ACA and Prescription Drug Coverage Requirements
The Affordable Care Act establishes prescription drug coverage as a federally mandated component of health insurance sold in the individual and small group markets. Understanding these requirements clarifies which plans must comply, what coverage must include, and how formulary design intersects with federal benefit standards. These rules carry practical weight for employers, insurers, and consumers navigating plan selection and compliance obligations.
Definition and Scope
Under the ACA, prescription drug coverage is one of ten Essential Health Benefits categories that non-grandfathered individual and small group market plans must include (42 U.S.C. § 18022). The Department of Health and Human Services (HHS) established this framework through regulations codified at 45 C.F.R. Part 156, which set the baseline benchmark methodology states use to define what counts as adequate drug coverage.
The scope of the mandate applies specifically to:
- Individual market plans sold on or off the ACA Marketplace
- Small group market plans (generally employers with 1–50 employees, or up to 100 in states that elected the expanded definition)
- Qualified Health Plans (QHPs) sold through HealthCare.gov or a state-based exchange
Large group and self-funded employer plans are not required to cover Essential Health Benefits under the ACA, though they remain subject to other federal rules — including the Mental Health Parity and Addiction Equity Act and, where applicable, ERISA fiduciary standards. For a full overview of how federal rules layer together, the regulatory context for ACA provides structured coverage of the governing framework.
Grandfathered plans — those that existed before March 23, 2010 and have not made significant changes — are also exempt from the Essential Health Benefits requirement, including the prescription drug mandate.
How It Works
The ACA does not define a single national drug formulary. Instead, HHS requires each state to establish a benchmark plan, and all compliant plans in that state must offer drug coverage at least as comprehensive as the benchmark (45 C.F.R. § 156.122). The benchmark is typically drawn from one of the three largest small group market plans in the state or another designated reference plan.
Plans must meet two structural tests to satisfy the prescription drug EHB standard:
- Formulary breadth: A plan must cover at least one drug in every United States Pharmacopeia (USP) category and class. The USP organizes drugs into approximately 146 categories and 1,049 classes, providing the structural grid against which formulary adequacy is measured.
- Non-discrimination: Plans cannot design formularies in ways that discriminate against enrollees based on health status, as prohibited under 45 C.F.R. § 156.125. Placing all drugs treating a specific condition — such as HIV medications — on the highest cost-sharing tier is a recognized discriminatory formulary design pattern flagged by HHS enforcement guidance.
Cost-sharing limits also apply. Out-of-pocket maximums cap total annual cost sharing for in-network essential benefits, including prescription drugs. For plan year 2024, HHS set the out-of-pocket maximum at $9,450 for self-only coverage and $18,900 for family coverage (HHS Notice of Benefit and Payment Parameters for 2024). Prescription drug costs count toward these limits for covered benefits.
The ACA plan design overview covers how drug coverage integrates with actuarial value calculations across metal tiers.
Common Scenarios
Scenario 1 — Specialty drug tier placement: An insurer places all biologics and specialty drugs on a 50% coinsurance tier with no out-of-pocket cap exception below the statutory maximum. Regulators scrutinizing the plan under 45 C.F.R. § 156.125 would examine whether tier design functions as a categorical barrier to enrollees with conditions like rheumatoid arthritis or multiple sclerosis, rather than a standard cost-management tool.
Scenario 2 — Mid-year formulary changes: A plan removes a covered drug during the plan year. HHS rules generally require plans to maintain formulary stability and provide adequate notice — typically 60 days — before removing a drug from coverage or moving it to a higher-cost tier, with exceptions for drugs withdrawn from the market or subject to new safety information.
Scenario 3 — Small employer plan selection: A small employer with 35 full-time employees selects a group health plan. Because small group plans are subject to Essential Health Benefits requirements, the selected plan must include the state benchmark's prescription drug coverage. Employers in this size range cannot legally purchase a group plan in the regulated market that omits drug coverage entirely.
Scenario 4 — Marketplace subsidized enrollment: An individual purchasing a Silver-tier plan through the ACA Marketplace applies for a premium tax credit. The plan's drug formulary must comply with the state benchmark standard as a condition of Marketplace certification, meaning the enrollee has a federally backed floor of drug coverage regardless of which certified insurer is chosen.
Decision Boundaries
The prescription drug coverage mandate draws distinct lines across plan type, market segment, and employer size:
| Dimension | Covered by Mandate | Exempt from Mandate |
|---|---|---|
| Market segment | Individual, small group | Large group, self-funded |
| Grandfathered status | Non-grandfathered | Grandfathered (pre-ACA) |
| Marketplace certification | All QHPs | N/A (must comply to certify) |
| Formulary standard | USP category/class floor | No EHB floor required |
A plan that is self-funded — regardless of employer size — is not required to include prescription drug coverage as an EHB. However, self-funded plans that choose to offer drug coverage must still comply with the ACA's prohibition on annual and lifetime dollar limits for any benefits they do cover (42 U.S.C. § 300gg-11).
The distinction between what a plan must cover and what it may not limit once covered is a recurring compliance boundary. A large group insured plan is not compelled to offer prescription drug benefits under EHB rules, but if it does offer drug coverage, annual limits on that coverage are prohibited under the same statutory framework.
The ACA's overall framework and its foundational provisions govern how these individual benefit mandates interact with the broader architecture of health reform, including market reforms, marketplace rules, and employer obligations.
References
- 42 U.S.C. § 18022 — Essential Health Benefits
- 45 C.F.R. § 156.122 — Prescription Drug Benefits (eCFR)
- 45 C.F.R. § 156.125 — Nondiscrimination in Essential Health Benefits (eCFR)
- 42 U.S.C. § 300gg-11 — Prohibition on Annual and Lifetime Limits
- HHS Center for Consumer Information and Insurance Oversight (CCIIO) — Regulations and Guidance
- United States Pharmacopeia (USP)
- Department of Health and Human Services (HHS)
The law belongs to the people. Georgia v. Public.Resource.Org, 590 U.S. (2020)